Geron (GERN) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026)
Powered by 
Analysis
Geron (GERN) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 24.68% |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 6.85% |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 24.71% |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 12.77% |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | -99.85% |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -5.07% |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 10.87% |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -3.38% |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Geron | 914.60 Mn | 613.75 Mn | - | -8.41% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -8.41% |
| Mar 31, 2026 | -12.82% |
| Dec 31, 2025 | -32.52% |
| Sep 30, 2025 | -39.00% |
| Jun 30, 2025 | -26.88% |
| Mar 31, 2025 | -31.77% |
| Dec 31, 2024 | 11.30% |
| Sep 30, 2024 | 29.57% |
| Jun 30, 2024 | 41.76% |
| Mar 31, 2024 | 57.69% |
| Dec 31, 2023 | 48.42% |
| Sep 30, 2023 | 67.94% |
| Jun 30, 2023 | 78.94% |
| Mar 31, 2023 | 65.79% |
| Dec 31, 2022 | 22.00% |
| Sep 30, 2022 | 20.56% |
| Jun 30, 2022 | 8.64% |
| Mar 31, 2022 | 3.71% |
| Dec 31, 2021 | -1.22% |
| Sep 30, 2021 | -11.76% |